Sandbox:iqra: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Line 39: Line 39:
!Plt
!Plt
|-
|-
|'''Congestive'''
| rowspan="3" |'''Congestive'''
|Cirrhosis
| colspan="2" |Cirrhosis
|
|
|
|
|
Line 68: Line 67:
|
|
|-
|-
|
| colspan="2" |Heart failure
|CHF
|
|
|
|
|
Line 97: Line 94:
|
|
|-
|-
|
| colspan="2" |Thrombosis of portal, hepatic, or splenic veins
|Thrombosis of portal, hepatic, or splenic veins
|
|
|
|
|
Line 126: Line 121:
|
|
|-
|-
|'''Malignancy'''
| rowspan="8" |'''Malignancy'''
|Lymphoma
| colspan="2" |Lymphoma
|
|
|
|
|
Line 155: Line 149:
|
|
|-
|-
|
| colspan="2" |Leukemias
|Leukemias
|
|
|
|
|
Line 184: Line 176:
|
|
|-
|-
|
| colspan="2" |Polycythemia vera
|Polycythemia vera
|
|
|
|
|
Line 213: Line 203:
|
|
|-
|-
|
| colspan="2" |Multiple myeloma
|Multiple myeloma
|
|
|
|
|
Line 242: Line 230:
|
|
|-
|-
|
| colspan="2" |Essential thrombocythemia
|Essential thrombocythemia
|
|
|
|
|
Line 271: Line 257:
|
|
|-
|-
|
| colspan="2" |Primary myelofibrosis
|Primary myelofibrosis
|
|
|
|
|
Line 300: Line 284:
|
|
|-
|-
|
| colspan="2" |Primary splenic tumors
|Primary splenic tumors
|
|
|
|
|
Line 329: Line 311:
|
|
|-
|-
|
| colspan="2" |Metastatic solid tumors
|Metastatic solid tumors
|
|
|
|
|
Line 358: Line 338:
|
|
|-
|-
|'''Infection'''
| rowspan="6" |'''Infection'''
|Viral
|Viral
|Hepatitis, infectious mononucleosis, cytomegalovirus
|Hepatitis, infectious mononucleosis, cytomegalovirus
Line 387: Line 367:
|
|
|-
|-
|
|Bacterial
|Bacterial
|Salmonella, Brucella, tuberculosis
|Salmonella, Brucella, tuberculosis
Line 416: Line 395:
|
|
|-
|-
|
| rowspan="2" |Parasitic  
|Parasitic  
|Malaria, schistosomiasis, toxoplasmosis
|Malaria, schistosomiasis, toxoplasmosis
|
|
Line 445: Line 423:
|
|
|-
|-
|
|
|Kala-azar (visceral leishmaniasis)
|Kala-azar (visceral leishmaniasis)
|
|
Line 474: Line 450:
|
|
|-
|-
|
| colspan="2" |Infective endocarditis
|Infective endocarditis
|
|
|
|
|
Line 503: Line 477:
|
|
|-
|-
|
| colspan="2" |Fungal
|Fungal
|
|
|
|
|
Line 532: Line 504:
|
|
|-
|-
|Inflammation
| rowspan="4" |Inflammation
|Sarcoid
| colspan="2" |Sarcoid
|
|
|
|
|
Line 561: Line 532:
|
|
|-
|-
|
| colspan="2" |Serum sickness
|Serum sickness
|
|
|
|
|
Line 590: Line 559:
|
|
|-
|-
|
| colspan="2" |Systemic lupus erythematosus
|Systemic lupus erythematosus
|
|
|
|
|
Line 619: Line 586:
|
|
|-
|-
|
| colspan="2" |Felty syndrome
|Felty syndrome
|
|
|
|
|
Line 648: Line 613:
|
|
|-
|-
|Infiltrative
| rowspan="6" |Infiltrative
|Gaucher disease
| colspan="2" |Gaucher disease
|
|
|
|
|
Line 677: Line 641:
|
|
|-
|-
|
| colspan="2" |Niemann-Pick disease
|Niemann-Pick disease
|
|
|
|
|
Line 706: Line 668:
|
|
|-
|-
|
| colspan="2" |Amyloidosis
|Amyloidosis
|
|
|
|
|
Line 735: Line 695:
|
|
|-
|-
|
| colspan="2" |Langerhans cell histiocytosis
|Langerhans cell histiocytosis
|
|
|
|
|
Line 764: Line 722:
|
|
|-
|-
|
| colspan="2" |Hemophagocytic lymphohistiocytosis
|Hemophagocytic lymphohistiocytosis
|
|
|
|
|
Line 793: Line 749:
|
|
|-
|-
|
| colspan="2" |Rosai-Dorfman disease
|Rosai-Dorfman disease
|
|
|
|
|
Line 822: Line 776:
|
|
|-
|-
|Hematologic (hypersplenic) states
| rowspan="3" |Hematologic (hypersplenic) states
|Hemolytic anemia
| colspan="2" |Hemolytic anemia
|
|
|
|
|
Line 851: Line 804:
|
|
|-
|-
|
| colspan="2" |Sickle cell disease
|Sickle cell disease
|
|
|
|
|
Line 880: Line 831:
|
|
|-
|-
|
| colspan="2" |Granulocyte colony-stimulating factor
|Granulocyte colony-stimulating factor
|
|
|
|
|

Revision as of 21:47, 25 September 2018

Splenomegaly differential:

Category Disease Etiology Clinical manifestations Para−clinical findings Gold standard Associated findings
Demography History Symptoms Signs Lab Findings Imaging
Fever Fatigue Weight loss SOB Bleeding BP JVP Jaundice Ascites Other CBC PS Iron LFT PT/PTT BUN/Cr UA
WBC Hb Plt
Congestive Cirrhosis
Heart failure
Thrombosis of portal, hepatic, or splenic veins
Malignancy Lymphoma
Leukemias
Polycythemia vera
Multiple myeloma
Essential thrombocythemia
Primary myelofibrosis
Primary splenic tumors
Metastatic solid tumors
Infection Viral Hepatitis, infectious mononucleosis, cytomegalovirus
Bacterial Salmonella, Brucella, tuberculosis
Parasitic Malaria, schistosomiasis, toxoplasmosis
Kala-azar (visceral leishmaniasis)
Infective endocarditis
Fungal
Inflammation Sarcoid
Serum sickness
Systemic lupus erythematosus
Felty syndrome
Infiltrative Gaucher disease
Niemann-Pick disease
Amyloidosis
Langerhans cell histiocytosis
Hemophagocytic lymphohistiocytosis
Rosai-Dorfman disease
Hematologic (hypersplenic) states Hemolytic anemia
Sickle cell disease
Granulocyte colony-stimulating factor
Category Disease Etiology Demography History Fever Fatigue Weight loss SOB Bleeding BP JVP Jaundice Ascites Other WBC Hb Plt PS Iron LFT PT/PTT BUN/Cr UA Imaging Gold standard Associated findings
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:iqra&oldid=1495399"